Jefferies Group LLC Fate Therapeutics Inc Transaction History

Jefferies Group LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$67.25 - $92.52 $1.08 Million - $1.49 Million	-16,100 Closed	0 $0
Q1 2021 Sep 21, 2023	BUY	$72.16 - $117.4 $1.16 Million - $1.89 Million	16,100 New	16,100 $1.33 Million
Q1 2021 May 14, 2021	BUY	$72.16 - $117.4 $1.16 Million - $1.89 Million	16,100 New	16,100 $1.33 Million
Q1 2020 May 15, 2020	SELL	$17.28 - $31.88 $945,717 - $1.74 Million	-54,729 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$13.39 - $20.73 $390,211 - $604,113	29,142 Added 113.89%	54,729 $1.07 Million
Q3 2019 Nov 13, 2019	BUY	$15.47 - $22.5 $395,830 - $575,707	25,587 New	25,587 $397,000

175

115M

53.7K

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $222M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.